US appeals court will not reconsider ruling upholding legality of "pay-for-delay" deals
This article was originally published in Scrip
Executive Summary
The full US Court of Appeals for the Second Circuit will not be taking a deeper review of patent settlements that come with payments to rivals and have the potential to delay introduction of generic drugs.